Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Drug Induced Liver Injury: full-pipeline trial registry
1 of 3 indexed Drug Induced Liver Injury trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Drug Induced Liver Injury: 3 US clinical trials tracked, 1 recruiting.
Drug Induced Liver Injury is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Kennon Heard, running 1 of these trials.
Enrollment posture brief
Registry condition drug-induced-liver-injury
OPEN 1 | RECR 33% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Drug Induced Liver Injury lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Drug Induced Liver Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Drug Induced Liver Injury is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Drug-Induced Liver Injury (DILI) Network Retrospective
Duke University
NCT00360646
Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions
Food and Drug Administration (FDA)
NCT06192589
Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days
Kennon Heard
NCT00616018
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Drug Induced Liver Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Drug Induced Liver Injury trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Drug Induced Liver Injury page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Drug Induced Liver Injury trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Kennon Heard sponsors the most Drug Induced Liver Injury trials on record, review their full trial history before evaluating a specific study. See Kennon Heard's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Drug Induced Liver Injury condition card totals 3 registered trials; most-linked intervention acetaminophen; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.